Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

DPYD antibody

The Rabbit Polyclonal anti-DPYD antibody has been validated for WB, IHC and ELISA. It is suitable to detect DPYD in samples from Human.
Catalog No. ABIN7178655
-15% Promotion 2026
$446.56
$525.36
save $78.80 (-15 %)
Plus shipping costs $50.00
100 μL
Shipping to: United States
Delivery in 13 to 16 Business Days

Quick Overview for DPYD antibody (ABIN7178655)

Target

See all DPYD Antibodies
DPYD (Dihydropyrimidine Dehydrogenase (DPYD))

Reactivity

  • 57
  • 18
  • 15
  • 1
  • 1
  • 1
Human

Host

  • 57
  • 3
Rabbit

Clonality

  • 46
  • 14
Polyclonal

Conjugate

  • 26
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This DPYD antibody is un-conjugated

Application

  • 47
  • 18
  • 15
  • 14
  • 14
  • 13
  • 13
  • 11
  • 7
  • 5
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Purpose

    DPYD Antibody

    Cross-Reactivity

    Mouse, Rat

    Purification

    Affinity purification

    Immunogen

    Recombinant protein of Human DPYD

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    DPYD (Dihydropyrimidine Dehydrogenase (DPYD))

    Alternative Name

    DPYD

    Background

    Background: Dihydropyrimidine dehydrogenase (DPD, DPYD) catalyzes the initial and rate-limiting step in uracil and thymidine catabolism as well as catabolism of the chemotherapeutic drug 5-fluorouracil (5-FU) and its derivatives. DPYD deficiency, which results from mutations in the DPYD gene, causes errors in pyrimidine metabolism and potentially life-threatening side effects in cancer patients treated with 5-FU (reviewed in 1). As a result, ongoing work examines whether or how DPYD gene variation and protein expression can be used to predict 5-FU toxicity. Several genes that impart resistance to 5-FU were recently identified in human hepatocellular carcinoma (HCC). AEG-1, which is highly expressed in HCC, increases the expression of DPYD. DPYD is expressed more highly in HCC than in normal liver, and this is thought to be one mechanism of 5-FU resistance.

    Aliases: DHP antibody, DHPDHase antibody, Dihydropyrimidine dehydrogenase [NADP(+)] antibody, Dihydropyrimidine dehydrogenase [NADP+] antibody, Dihydropyrimidine dehydrogenase antibody, Dihydrothymine dehydrogenase antibody, Dihydrouracil dehydrogenase antibody, DPD antibody, DPYD antibody, DPYD_HUMAN antibody, MGC132008 antibody, MGC70799 antibody, OTTHUMP00000058954 antibody

    UniProt

    Q12882

    Pathways

    Ribonucleoside Biosynthetic Process
You are here:
Chat with us!